Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ergot derivatives for Parkinsonism.

D B Calne, A C Williams, J G Nutt

    The Medical Journal of Australia
    |November 4, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gut bacteria promote proliferation in benign S/RG/C2 colorectal tumour cells, and promote proliferation, migration and invasion in malignant HCT116 cells.

    Scientific reports·2023
    Same author

    Landscape characteristics influence ranging behavior of Asian elephants at the human-wildlands interface in Myanmar.

    Movement ecology·2022
    Same author

    Post-publication science: introducing the Peer Perspectives.

    Human reproduction (Oxford, England)·2021
    Same author

    Factors associated with advanced colorectal cancer differ between young and older adults in England: a population-based cohort study.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
    Same author

    Safety first - assisted human reproduction second.

    Human reproduction (Oxford, England)·2020
    Same author

    Demographic trends in the incidence of young-onset colorectal cancer: a population-based study.

    The British journal of surgery·2020

    This study evaluated ergot derivatives for Parkinsonism. Bromocriptine showed effectiveness, especially when combined with levodopa, but long-term tolerance was limited.

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Parkinsonism is a neurological disorder affecting motor control.
    • Dopaminergic transmission is a key pathway implicated in Parkinsonism.
    • Ergot derivatives are compounds that can modulate dopaminergic activity.

    Purpose of the Study:

    • To investigate the efficacy of three ergot derivatives in treating Parkinsonism.
    • To compare the agonist and antagonist properties of these compounds.
    • To assess the therapeutic potential and adverse effects of these agents.

    Main Methods:

    • Studied the response of Parkinsonism to three ergot derivatives: CF 25-397, lergotrile, and bromocriptine.
    • Evaluated dopaminergic transmission modification.
    • Assessed therapeutic effects and toxicity, particularly hepatotoxicity.

    Related Experiment Videos

    Main Results:

    • CF 25-397 acted more as an antagonist than an agonist.
    • Lergotrile demonstrated agonist properties but caused significant hepatotoxicity.
    • Bromocriptine proved effective, especially for levodopa-induced dyskinesia and "on-off" phenomena, often in combination with reduced levodopa dosage.

    Conclusions:

    • Bromocriptine is a valuable anti-Parkinsonian agent, particularly for specific patient subgroups.
    • Combination therapy with bromocriptine and levodopa can optimize treatment outcomes.
    • Bromocriptine's adverse effects are dose-dependent and reversible, though long-term tolerability affects approximately 50% of patients.